Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SCOTT T HAMLER

Allopathic & Osteopathic Physicians Family Medicine

NPI
1538178298
CMS profile
160579
Location
UNIONTOWN, OH

General Payments · PY2022–2024

$305.54

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$252.57

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $252.57 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $45.32 3
ABBVIE INC. $42.32 2
Sumitomo Pharma America, Inc. $37.31 2
GlaxoSmithKline, LLC. $36.64 2
ViiV Healthcare Company $23.00 1
ITI, Inc. $21.78 1
Exact Sciences Corporation $17.74 1
Lilly USA, LLC $14.89 1
Novo Nordisk AS $13.57 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $15.80 1
PY2023 $37.17 2
PY2024 $252.57 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.63 03/11/2024 Food and Beverage Undisputed 01/23/2026 1103870129 CMS
ABBVIE INC. $23.69 06/04/2024 Food and Beverage Undisputed 01/23/2026 1103870131 CMS
AstraZeneca Pharmaceuticals LP $16.34 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104674319 CMS
AstraZeneca Pharmaceuticals LP $13.38 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104759524 CMS
AstraZeneca Pharmaceuticals LP $15.60 10/28/2024 Food and Beverage Undisputed 01/23/2026 1104480018 CMS
Exact Sciences Corporation $17.74 06/24/2024 Food and Beverage Undisputed 01/23/2026 1114690888 CMS
GlaxoSmithKline, LLC. $16.91 07/08/2024 Food and Beverage Undisputed 01/23/2026 1116644906 CMS
GlaxoSmithKline, LLC. $19.73 11/04/2024 Food and Beverage Undisputed 01/23/2026 1116479659 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.78 06/19/2024 Food and Beverage Undisputed 01/23/2026 1143238495 CMS
Lilly USA, LLC $14.89 05/15/2024 Food and Beverage Undisputed 01/23/2026 1135411283 CMS
Novo Nordisk Inc $13.57 12/16/2024 Food and Beverage Undisputed 01/23/2026 1096795631 CMS
Sumitomo Pharma America, Inc. $18.25 02/12/2024 Food and Beverage Undisputed 01/23/2026 1148861249 CMS
Sumitomo Pharma America, Inc. $19.06 06/06/2024 Food and Beverage Undisputed 01/23/2026 1148861251 CMS
ViiV Healthcare Company $23.00 01/16/2024 Food and Beverage Undisputed 01/23/2026 1112707956 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.